Author:
Lu Jiaojiao,Pan Qiongqun,Zhou Jieqiang,Weng Yan,Chen Kaili,Shi Lv,Zhu Guanxiu,Chen Chunlin,Li Liang,Geng Meiyu,Zhang Zhenqing
Funder
Priority Academic Program Development of Jiangsu Higher Education Institutions
Subject
Analytical Chemistry,Electrochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Pharmacy
Reference34 articles.
1. A phase II randomized trial of sodium oligomannate in Alzheimer’s dementia;Wang;Alzheimer's Res. Ther.,2020
2. A 36-week multicenter, randomized, double-blind, placebocontrolled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to- moderate Alzheimer disease;Xiao;Alzheimer's Res. Ther.,2021
3. News at a glance;Science,2019
4. Sodium oligomannate: first approval;Syed;Drugs,2020
5. Clinical trials for disease-modifying therapies in Alzheimer’s disease: a primer, lessons learned, and a blueprint for the future;Cummings;J. Alzheimers Dis.,2018
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献